Huafei Chen

577 total citations
37 papers, 328 citations indexed

About

Huafei Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Huafei Chen has authored 37 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Huafei Chen's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (8 papers) and Optimization and Variational Analysis (5 papers). Huafei Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (8 papers) and Optimization and Variational Analysis (5 papers). Huafei Chen collaborates with scholars based in China and United States. Huafei Chen's co-authors include C. Xu, Wenxian Wang, You‐cai Zhu, Lixin Wu, Zhengbo Song, Kaiqi Du, Xiaofeng Li, Liping Wang, Huijing Feng and Jinhao Jia and has published in prestigious journals such as PLoS ONE, Frontiers in Oncology and Lung Cancer.

In The Last Decade

Huafei Chen

32 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huafei Chen China 11 209 172 102 75 35 37 328
Satomi Yamamoto Japan 8 173 0.8× 193 1.1× 118 1.2× 61 0.8× 33 0.9× 22 366
Letizia Laera Italy 12 179 0.9× 119 0.7× 101 1.0× 72 1.0× 25 0.7× 32 329
Umair Majeed United States 5 159 0.8× 149 0.9× 95 0.9× 81 1.1× 16 0.5× 27 295
Seiji Kosaihira Japan 9 227 1.1× 174 1.0× 153 1.5× 53 0.7× 32 0.9× 14 361
Luigi Cerbone Italy 10 222 1.1× 125 0.7× 109 1.1× 93 1.2× 13 0.4× 40 308
Andrew Erickson Finland 13 254 1.2× 122 0.7× 116 1.1× 91 1.2× 16 0.5× 40 417
Pablo Lee United States 13 225 1.1× 270 1.6× 123 1.2× 66 0.9× 15 0.4× 21 432
María González Cao Spain 12 107 0.5× 207 1.2× 144 1.4× 33 0.4× 28 0.8× 38 336
Francesca Sperandi Italy 12 239 1.1× 346 2.0× 137 1.3× 60 0.8× 73 2.1× 50 511
Priscilla Cascetta Italy 10 135 0.6× 234 1.4× 142 1.4× 84 1.1× 57 1.6× 15 368

Countries citing papers authored by Huafei Chen

Since Specialization
Citations

This map shows the geographic impact of Huafei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huafei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huafei Chen more than expected).

Fields of papers citing papers by Huafei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huafei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huafei Chen. The network helps show where Huafei Chen may publish in the future.

Co-authorship network of co-authors of Huafei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Huafei Chen. A scholar is included among the top collaborators of Huafei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huafei Chen. Huafei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wan, Dong, Si Chen, Huafei Chen, et al.. (2024). Case report: Germline CHEK2 mutation is associated with a giant cell glioblastoma. Frontiers in Oncology. 14. 1361928–1361928.
2.
Qu, Dan, et al.. (2024). An improved differential evolution algorithm for multi-modal multi-objective optimization. PeerJ Computer Science. 10. e1839–e1839. 4 indexed citations
3.
Qian, Jun, Min Peng, Yanan Li, et al.. (2024). Case report: A germline CHEK1 c.613 + 2T>C leads to a splicing error in a family with multiple cancer patients. Frontiers in Oncology. 14. 1380093–1380093.
4.
Chen, Huafei, et al.. (2023). Research on the Coordination of Fresh Food Supply Chain Based on the Perspective of Blockchain and Low Carbon. Discrete Dynamics in Nature and Society. 2023. 1–20. 2 indexed citations
5.
Chen, Huafei, et al.. (2022). An Uncertain Sandwich Impulsive Control System with Impulsive Time Windows. Mathematics. 10(24). 4708–4708. 4 indexed citations
6.
Li, Hecheng, et al.. (2022). An evolutionary algorithm based on approximation method and related techniques for solving bilevel programming problems. PLoS ONE. 17(8). e0273564–e0273564. 3 indexed citations
7.
Wang, Wenxian, Xiaodong Gu, Xingxiang Pu, et al.. (2022). Treatment outcomes and prognosis of patients with primary and acquired BRAF‐mutated non‐small cell lung cancer: A multicenter retrospective study. Genes Chromosomes and Cancer. 61(9). 530–541. 4 indexed citations
9.
Song, Zhengbo, Dongqing Lv, Shiqing Chen, et al.. (2021). Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study. Frontiers in Oncology. 11. 657283–657283. 10 indexed citations
10.
Chen, Dong, Xingliang Li, Wu B, et al.. (2020). A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib. Frontiers in Oncology. 10. 867–867. 10 indexed citations
11.
Chen, Huafei, Wenxian Wang, Xiaofeng Li, et al.. (2020). Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: A case report. World Journal of Clinical Cases. 8(2). 410–414. 5 indexed citations
12.
Chen, Huafei, Wenxian Wang, C. Xu, et al.. (2020). A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinib. Lung Cancer. 142. 59–62. 11 indexed citations
13.
Pu, Xingxiang, Liping Wang, Zongyang Yu, et al.. (2020). Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study. Clinical Lung Cancer. 21(5). e349–e354. 27 indexed citations
14.
Wu, Lixin, Lei Lei, You‐cai Zhu, et al.. (2020). A prostate cancer patient with isolated lung metastases: a case report. Translational Cancer Research. 9(3). 2064–2068. 10 indexed citations
15.
Chen, Huafei, Lixin Wu, Xiaofeng Li, et al.. (2020). PD-L1 expression level in different thymoma stages and thymic carcinoma: a meta-analysis. Tumori Journal. 106(4). 306–311. 9 indexed citations
16.
Lei, Lei, Wenxian Wang, Zongyang Yu, et al.. (2019). A Real-World Study in Advanced Non–Small Cell Lung Cancer with KRAS Mutations. Translational Oncology. 13(2). 329–335. 25 indexed citations
17.
Chen, Huafei, Lei Lei, Lixin Wu, et al.. (2019). Effect of icotinib on advanced lung adenocarcinoma patients with sensitive EGFR mutation detected in ctDNA by ddPCR. Translational Cancer Research. 8(8). 2858–2863. 5 indexed citations
18.
Zhu, You‐cai, Xueping Lin, Wenxian Wang, et al.. (2019). Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1‑positive non‑small cell lung cancer. Oncology Letters. 17(3). 3466–3474. 13 indexed citations
19.
Chen, Huafei, You‐cai Zhu, Kaiqi Du, et al.. (2018). Intestinal metastasis from primary<em> ROS1</em>-positive lung adenocarcinoma cancer patients responding to crizotinib. OncoTargets and Therapy. Volume 11. 7821–7825. 3 indexed citations
20.
Li, Hecheng, et al.. (2018). A Genetic Algorithm for Solving Linear Integer Bilevel Programming Problems. 40–44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026